Mainz Biomed N.V.
QUCY
$0.43
-$0.03-6.65%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 125.20K | 125.20K | 143.40K | 143.40K | 186.60K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 125.20K | 125.20K | 143.40K | 143.40K | 186.60K |
| Cost of Revenue | 25.10K | 25.10K | 48.60K | 48.60K | 58.70K |
| Gross Profit | 100.10K | 100.10K | 94.80K | 94.80K | 127.90K |
| SG&A Expenses | 1.85M | 1.85M | 2.61M | 2.61M | 3.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.83M | 2.83M | 4.19M | 4.19M | 4.53M |
| Operating Income | -2.70M | -2.70M | -4.05M | -4.05M | -4.34M |
| Income Before Tax | -3.93M | -3.93M | -4.17M | -4.17M | -5.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.93M | -3.93M | -4.17M | -4.17M | -5.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.93M | -3.93M | -4.17M | -4.17M | -5.29M |
| EBIT | -2.70M | -2.70M | -4.05M | -4.05M | -4.34M |
| EBITDA | -2.57M | -2.57M | -3.87M | -3.87M | -4.24M |
| EPS Basic | -0.44 | -0.44 | -1.33 | -1.33 | -3.74 |
| Normalized Basic EPS | -0.18 | -0.18 | -0.83 | -0.83 | -1.96 |
| EPS Diluted | -0.44 | -0.44 | -1.33 | -1.33 | -3.74 |
| Normalized Diluted EPS | -0.18 | -0.18 | -0.83 | -0.83 | -1.96 |
| Average Basic Shares Outstanding | 8.85M | 8.85M | 3.14M | 3.14M | 1.41M |
| Average Diluted Shares Outstanding | 8.85M | 8.85M | 3.14M | 3.14M | 1.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |